Status:
COMPLETED
Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography
Lead Sponsor:
NYU Langone Health
Conditions:
Diabetes Mellitus
Coronary Artery Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
There are 24 million people with diabetes mellitus (DM) in the United States. Over one-third of patients presenting for coronary angiography have known DM, and an additional 20% of patients without kn...
Eligibility Criteria
Inclusion
- All patients undergoing coronary angiography at the Manhattan Campus of the VA NY Harbor Healthcare System
Exclusion
- 1\. Patients who do not or are unable to consent. 2. Patients participating in a competing study. 3. For platelet substudy, patients who took NSAIDs within 72 hours of blood collection or who are on cilostazol or dipyridamole as part of their routine medication regimen. 4. Patients with any other co-morbidities that would influence subject safety.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT01419652
Start Date
July 1 2009
End Date
June 1 2012
Last Update
June 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA New York Harbor
New York, New York, United States, 10010